MelanomaA study looking at a new blood test to find cancer early (MODERNISED)
This study is looking to see if a new blood test can help to spot cancer early.
Melanoma
Available
Available
Melanoma skin cancer
A study looking at a blood test to see whether further treatment is needed after having surgery to remove melanoma skin cancer (DETECTION-2)
This is a feasibility study looking at using a blood test called circulating tumour DNA to see if further treatment is needed after having melanoma surgery.
A study using the ASICA app to help people who have had treatment for melanoma (ASICA Optimization Project)
This study is looking at improving the ASICA melanoma app to better support people to check their skin monthly.
A study looking at V940 immunotherapy with pembrolizumab for people with high risk melanoma (INTerpath-001)
This study is looking at an immunotherapy treatment called V940 (mRNA-4157) with pembrolizumab to treat melanoma.
A study to collect information about the causes and treatment of melanoma skin cancer (MyMelanoma)
This study is to collect information about melanoma causes and treatment. It is open people who have or had melanoma and their family members.
A trial using circulating tumour DNA to work out when to switch between targeted treatment and immunotherapy for melanoma (CAcTUS)
This trial is looking at whether measuring circulating tumour DNA can help doctors work out the best time to switch treatment for people with melanoma.
A study of the drug tebentafusp for melanoma (TebeMRD)
This study is looking at a type of immunotherapy called tebentafusp. It is for people with melanoma of the skin (cutaneous), or of the eye (uveal).
A trial looking at when to give radiotherapy for cancer that has spread to the brain (USZ-STRIKE)
This trial is looking at the best time to give radiotherapy to people whose primary cancer has spread to the brain
A trial of encorafenib and binimetinib for melanoma that has spread (PREMIUM)
This trial is looking at 2 drugs called encorafenib and binimetinib before and after surgery for melanoma.
Non-melanoma skin cancer mortality projections
Non-melanoma skin cancer mortality rates are projected to fall by 9% in the UK between 2023-2025 and 2038-2040.
There could be around around 710 deaths of non-melanoma skin cancer every year in the UK by 2038-2040, projections suggest.